INNOVATIVE SUSPENSIONS ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  2.2% 5.7% 2.1% 2.6% 8.5%  
Credit score (0-100)  67 40 66 61 28  
Credit rating  BBB BBB A BBB BB  
Credit limit (kDKK)  0.0 0.0 0.1 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  995 860 1,068 1,025 990  
EBITDA  704 111 319 174 -51.7  
EBIT  597 36.2 255 123 -54.4  
Pre-tax profit (PTP)  578.9 17.2 225.9 115.5 -60.0  
Net earnings  451.6 13.4 176.2 89.8 -54.8  
Pre-tax profit without non-rec. items  579 17.2 226 116 -60.0  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  1,111 906 842 791 42.9  
Shareholders equity total  897 856 977 907 447  
Interest-bearing liabilities  327 115 0.0 0.0 0.0  
Balance sheet total (assets)  1,597 1,403 1,268 1,064 622  

Net Debt  327 115 -139 -147 -423  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  995 860 1,068 1,025 990  
Gross profit growth  110.2% -13.6% 24.2% -4.1% -3.3%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,597 1,403 1,268 1,064 622  
Balance sheet change%  133.2% -12.2% -9.6% -16.1% -41.6%  
Added value  704.4 111.2 319.5 186.9 -51.7  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  724 -280 -129 -102 -750  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 2.0 3.0 4.0 -1.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  60.0% 4.2% 23.9% 12.0% -5.5%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  52.3% 2.4% 19.1% 10.5% -6.4%  
ROI %  68.0% 3.3% 26.1% 13.0% -8.0%  
ROE %  64.7% 1.5% 19.2% 9.5% -8.1%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  56.1% 61.0% 77.0% 85.2% 71.9%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  46.4% 103.5% -43.6% -84.8% 819.0%  
Gearing %  36.5% 13.4% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  10.8% 8.6% 50.6% 0.0% 0.0%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.4 0.0 0.5 1.0 2.5  
Current Ratio  0.4 0.1 0.7 1.7 3.2  
Cash and cash equivalent  0.0 0.0 139.4 147.4 423.2  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -411.9 -460.1 -95.3 116.2 377.7  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0